Skip to main content
Top
Published in: Current Rheumatology Reports 12/2023

Open Access 14-11-2023 | Telemedicine

Digital Approaches for Myositis

Authors: Johannes Knitza, Sebastian Kuhn, Latika Gupta

Published in: Current Rheumatology Reports | Issue 12/2023

Login to get access

Abstract

Purpose of Review

This article serves as a comprehensive review, focusing on digital approaches utilized in the diagnosis, monitoring, and treatment of patients with idiopathic inflammatory myopathies (IIM). The authors critically assess the literature published in the last three years, evaluating the advancements and progress achieved in this specific domain.

Recent Findings

Remarkable strides have been made in the realm of digital diagnostic support, particularly in image analysis and clinical prediction models, showing promise in aiding the diagnosis of IIM. The field of remote patient monitoring has also witnessed significant advancements, revolutionizing the care process by offering more convenient, data-driven, and continuous monitoring for IIM patients. Various digital tools, such as wearables, video- and voice consultations, and electronic patient-reported outcomes, have been extensively explored and implemented to enhance patient care. Survey studies consistently reveal a high acceptance of telehealth services among patients. Additionally, internet-based studies have facilitated the efficient and rapid recruitment of IIM patients for research purposes. Moreover, the integration of sensors and exoskeletons has shown great potential in significantly improving the functionality and quality of life for individuals with muscle weakness caused by IIM.

Summary

The integration of digital health solutions in the care of IIM patients is steadily gaining attention and exploration. Although the existing evidence is limited, it does indicate that patients can be adequately and safely supported through digital means throughout their entire healthcare journey. The growing interest in digital health technologies holds the promise of improving the overall management and outcomes for individuals with idiopathic inflammatory myopathies.
Literature
7.
go back to reference Knitza J, Muehlensiepen F, Ignatyev Y, et al. Patient’s perception of digital symptom assessment technologies in rheumatology: results from a multicentre study. Frontiers. Public Health. 2022;10 Knitza J, Muehlensiepen F, Ignatyev Y, et al. Patient’s perception of digital symptom assessment technologies in rheumatology: results from a multicentre study. Frontiers. Public Health. 2022;10
18.
21.
go back to reference Aggarwal R, Rider LG, Ruperto N, et al. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2017;76:792–801. https://doi.org/10.1136/annrheumdis-2017-211400CrossRefPubMed Aggarwal R, Rider LG, Ruperto N, et al. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2017;76:792–801. https://​doi.​org/​10.​1136/​annrheumdis-2017-211400CrossRefPubMed
Metadata
Title
Digital Approaches for Myositis
Authors
Johannes Knitza
Sebastian Kuhn
Latika Gupta
Publication date
14-11-2023
Publisher
Springer US
Published in
Current Rheumatology Reports / Issue 12/2023
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-023-01119-4

Other articles of this Issue 12/2023

Current Rheumatology Reports 12/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine